Early G1 Cyclin-Dependent Kinases as Prognostic Markers and Potential Therapeutic Targets in Esophageal Adenocarcinoma

MLA

Tony E. Godfrey, et al. “Early G1 Cyclin-Dependent Kinases as Prognostic Markers and Potential Therapeutic Targets in Esophageal Adenocarcinoma.” Clinical Cancer Research, vol. 17, July 2011, pp. 4513–22. EBSCOhost, https://doi.org/10.1158/1078-0432.ccr-11-0244.

APA

Tony E. Godfrey, William E. Gooding, Jeffrey H. Peters, James D. Luketich, Lincoln Stein, Irina Kalatskaya, Arjun Pennathur, Zhongren Zhou, Mary D’Souza, Marie Reveiller, Virginia R. Litle, Santhoshi Bandla, Amin Ismail, & Liana Toia. (2011). Early G1 Cyclin-Dependent Kinases as Prognostic Markers and Potential Therapeutic Targets in Esophageal Adenocarcinoma. Clinical Cancer Research, 17, 4513–4522. https://doi.org/10.1158/1078-0432.ccr-11-0244

Chicago

Tony E. Godfrey, William E. Gooding, Jeffrey H. Peters, James D. Luketich, Lincoln Stein, Irina Kalatskaya, Arjun Pennathur, et al. 2011. “Early G1 Cyclin-Dependent Kinases as Prognostic Markers and Potential Therapeutic Targets in Esophageal Adenocarcinoma.” Clinical Cancer Research 17 (July): 4513–22. doi:10.1158/1078-0432.ccr-11-0244.